157 related articles for article (PubMed ID: 24365202)
1. FDG uptake heterogeneity in FIGO IIb cervical carcinoma does not predict pelvic lymph node involvement.
Brooks FJ; Grigsby PW
Radiat Oncol; 2013 Dec; 8():294. PubMed ID: 24365202
[TBL] [Abstract][Full Text] [Related]
2. Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with
Lin AJ; Wright JD; Dehdashti F; Siegel BA; Markovina S; Schwarz J; Thaker PH; Mutch DG; Powell MA; Grigsby PW
Int J Gynecol Cancer; 2019 Nov; 29(9):1351-1354. PubMed ID: 31473660
[TBL] [Abstract][Full Text] [Related]
3. Pelvic lymph node F-18 fluorodeoxyglucose uptake as a prognostic biomarker in newly diagnosed patients with locally advanced cervical cancer.
Kidd EA; Siegel BA; Dehdashti F; Grigsby PW
Cancer; 2010 Mar; 116(6):1469-75. PubMed ID: 20108309
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer.
Hong JH; Min KJ; Lee JK; So KA; Jung US; Kim S; Eo JS
Medicine (Baltimore); 2016 Mar; 95(9):e2992. PubMed ID: 26945420
[TBL] [Abstract][Full Text] [Related]
5. Value of [
Li K; Sun H; Lu Z; Xin J; Zhang L; Guo Y; Guo Q
Eur J Radiol; 2018 Sep; 106():160-166. PubMed ID: 30150039
[TBL] [Abstract][Full Text] [Related]
6. Combinative evaluation of primary tumor and lymph nodes in predicting pelvic lymphatic metastasis in early-stage cervical cancer: A multiparametric PET-CT study.
Li K; Sun H; Guo Q
Eur J Radiol; 2019 Apr; 113():153-157. PubMed ID: 30927941
[TBL] [Abstract][Full Text] [Related]
7. 18F-FDG-PET/CT is of limited value in primary staging of early stage cervical cancer.
Driscoll DO; Halpenny D; Johnston C; Sheehy N; Keogan M
Abdom Imaging; 2015 Jan; 40(1):127-33. PubMed ID: 25015401
[TBL] [Abstract][Full Text] [Related]
8. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.
Tsai CS; Chang TC; Lai CH; Tsai CC; Ng KK; Hsueh S; Yen TC; Hong JH
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1506-12. PubMed ID: 15050330
[TBL] [Abstract][Full Text] [Related]
9. FDG-PET lymph node staging and survival of patients with FIGO stage IIIb cervical carcinoma.
Singh AK; Grigsby PW; Dehdashti F; Herzog TJ; Siegel BA
Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):489-93. PubMed ID: 12738325
[TBL] [Abstract][Full Text] [Related]
10. [Application of (18)F-fluorodeoxyglucose Metabolic Imaging in Diagnosis and Treatment of Cervical Cancer].
Li H; Li S; Jing X; Pang H; Duan D; You J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2016 Dec; 33(6):1145-51. PubMed ID: 29714980
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of volume-based metabolic parameters in uterine cervical cancer determined using 18F-fluorodeoxyglucose positron emission tomography.
Yoo J; Choi JY; Moon SH; Bae DS; Park SB; Choe YS; Lee KH; Kim BT
Int J Gynecol Cancer; 2012 Sep; 22(7):1226-33. PubMed ID: 22810970
[TBL] [Abstract][Full Text] [Related]
12. Preoperative PET/CT FDG standardized uptake value of pelvic lymph nodes as a significant prognostic factor in patients with uterine cervical cancer.
Chung HH; Cheon GJ; Kang KW; Kim JW; Park NH; Song YS
Eur J Nucl Med Mol Imaging; 2014 Apr; 41(4):674-81. PubMed ID: 24233005
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of
Isaji Y; Tsuyoshi H; Tsujikawa T; Orisaka M; Okazawa H; Yoshida Y
Sci Rep; 2023 Nov; 13(1):18864. PubMed ID: 37914892
[TBL] [Abstract][Full Text] [Related]
14. False negative rate at
Gouy S; Seebacher V; Chargari C; Terroir M; Grimaldi S; Ilenko A; Maulard A; Genestie C; Leary A; Pautier P; Morice P; Deandreis D
BMC Cancer; 2021 Feb; 21(1):135. PubMed ID: 33549033
[TBL] [Abstract][Full Text] [Related]
15. Histologic results of para-aortic lymphadenectomy in patients treated for stage IB2/II cervical cancer with negative [18F]fluorodeoxyglucose positron emission tomography scans in the para-aortic area.
Boughanim M; Leboulleux S; Rey A; Pham CT; Zafrani Y; Duvillard P; Lumbroso J; Haie-Meder C; Schlumberger M; Morice P
J Clin Oncol; 2008 May; 26(15):2558-61. PubMed ID: 18487573
[TBL] [Abstract][Full Text] [Related]
16. The role of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (18F-FDG-PET) in the diagnosis of recurrence and lymph node metastasis of cervical cancer.
Umesaki N; Tanaka T; Miyama M; Kawabe J; Okamura T; Koyama K; Ochi H; Ogita S
Oncol Rep; 2000; 7(6):1261-4. PubMed ID: 11032926
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of pretherapeutic 18F-FDG PET/CT in cancer of the uterine cervix: a retrospective study of 53 patients].
Chastan M; Manrique A; Baron M; Sanson AE; Diologent B; Vera P; Hitzel A
Gynecol Obstet Fertil; 2010 Apr; 38(4):244-9. PubMed ID: 20359931
[TBL] [Abstract][Full Text] [Related]
18. A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy.
Tsai CS; Lai CH; Chang TC; Yen TC; Ng KK; Hsueh S; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):477-84. PubMed ID: 19464824
[TBL] [Abstract][Full Text] [Related]
19. [18F-FDG positron-emission-tomography in cervical carcinoma: preliminary findings].
Kühnel G; Horn LC; Fischer U; Hesse S; Seese A; Georgi P; Kluge R
Zentralbl Gynakol; 2001 Apr; 123(4):229-35. PubMed ID: 11370532
[TBL] [Abstract][Full Text] [Related]
20. Prognostic importance of lymph node-to-primary tumor standardized uptake value ratio in invasive squamous cell carcinoma of uterine cervix.
Chung HH; Cheon GJ; Kim JW; Park NH; Song YS
Eur J Nucl Med Mol Imaging; 2017 Oct; 44(11):1862-1869. PubMed ID: 28534183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]